We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Advertisement
Sigma and Czech Center for Phenogenomics Collaborate
News

Sigma and Czech Center for Phenogenomics Collaborate

Sigma and Czech Center for Phenogenomics Collaborate
News

Sigma and Czech Center for Phenogenomics Collaborate

Read time:
 

Want a FREE PDF version of This News Story?

Complete the form below and we will email you a PDF version of "Sigma and Czech Center for Phenogenomics Collaborate"

First Name*
Last Name*
Email Address*
Country*
Company Type*
Job Function*
Would you like to receive further email communication from Technology Networks?

Technology Networks Ltd. needs the contact information you provide to us to contact you about our products and services. You may unsubscribe from these communications at any time. For information on how to unsubscribe, as well as our privacy practices and commitment to protecting your privacy, check out our Privacy Policy

Sigma-Aldrich Corporation's Research business unit, which supports scientific research by supplying products, services and solutions, has announced it has entered into a new gene editing collaboration with the Institute of Molecular Genetics (IMG) at the Czech Center for Phenogenomics (CCP) in Prague. Under the collaboration, Sigma-Aldrich will provide the Transgenic Module at IMG/CCP with Sigma CRISPR technology, including reagents, experimental design consultation and dedicated gene editing bioinformaticians.

"We are pleased to collaborate with the Czech Center for Phenogenomics at the IMG," said Sean Muthian, Ph.D., MBA, Director of Strategic Marketing and Collaborations at Sigma-Aldrich. "The Sigma-Aldrich CRISPR Core Lab Collaboration helps accelerate the pace of translational research by removing design and production hurdles with CRISPR or Zinc Finger Nucleases, allowing scientists at the transgenic facility to focus on developing animal models that reflect the human condition."

"Employing new technologies based on custom programmable nucleases, such as the CRISPR/Cas technology, into our service portfolio reduced turnaround times over 75% compared to conventional methods," said Radislav Sedlacek, Ph.D., Director of the Czech Center for Phenogenomics. "Now rodents harboring targeted genetic mutations, including knockin, point mutations, and fusion proteins, can be produced in as little as six weeks, and at a fraction of the previous cost. Not surprisingly, service requests for these technologies have undergone substantial growth over the past year, reaching almost 100 projects at the end of 2014. Our collaboration with Sigma-Aldrich will allow us to further improve our service efficiency and keep pace with our growing order book."

"With the availability of our CRISPR Technology, scientists will be able to more consistently and confidently modify genes of interest leading to more reproducible outcomes in their research. Our collaboration with the Institute of Molecular Genetics/Czech Center for Phenogenomics is an example of how Sigma-Aldrich is making available technologies to improve reproducibility for scientists," said Muthian.

Advertisement